SPEED OF LIFE

– Building a strong and sustainable Life science sector – together

Ilya Pharma is developing next-generation immunotherapies to treat wounds in skin and mucosa

 

The ILP-technology is based on deploying chemokines, which until now have been regarded too unstable to be suitable as therapeutics. Ilya Pharma has overcome this problem by letting live lactic acid bacteria produce and deliver the human therapeutic chemokines on site in wounds in skin or e.g in the intestine acting like small bioreactors. In addition to the documented biologic and clinical effect on accelerating the healing and recovery, it is a very cost efficient system to deliver drugs, compared to cell therapies and other traditional biologics.

Read more about Ilya Pharma

Presented by Björn Arvidsson and Dajana Ilic S from STUNS Life science, featuring Evelina Vågesjö CEO, Mia Phillipson Co-founder and Stefan Roos Co-founder at Ilya Pharma AB.

ABOUT THE PODCAST

SPEED OF LIFE
– Building a strong and sustainable Life science sector – together

Company representatives from the prosperous Life science industry, will share their journey, success strategies and examples concerning entrepreneurship. Business leaders, researchers, marketers, economists, business developers and other experts jointly describe the environment their companies operate in, what drives them and what challenges they face.

Listen, be inspired, learn and take the insights to your company and gain value today!

Picture: Logo of the European Regional Development Fund